TK2 and neoplasm: The effect was specific to TK2, as knockdown of other dTMP-producing enzymes (thymidylate synthase and TK1), alone or in combination with TK2 siRNA treatment, did not further sensitize tumor cells to gemcitabine beyond that induced by TK2 knockdown alone.